Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Shares Bought by Ballast Asset Management LP

Ballast Asset Management LP lifted its position in shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX) by 23.5% during the 4th quarter, HoldingsChannel.com reports. The fund owned 431,887 shares of the company’s stock after acquiring an additional 82,187 shares during the quarter. Ballast Asset Management LP’s holdings in Bioceres Crop Solutions were worth $2,620,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in the company. JPMorgan Chase & Co. increased its stake in Bioceres Crop Solutions by 49.3% during the third quarter. JPMorgan Chase & Co. now owns 89,973 shares of the company’s stock valued at $708,000 after purchasing an additional 29,693 shares during the last quarter. Stifel Financial Corp boosted its holdings in shares of Bioceres Crop Solutions by 33.4% in the 3rd quarter. Stifel Financial Corp now owns 40,790 shares of the company’s stock valued at $321,000 after buying an additional 10,224 shares during the period. Fourth Sail Capital LP grew its position in shares of Bioceres Crop Solutions by 16.6% during the 4th quarter. Fourth Sail Capital LP now owns 3,698,961 shares of the company’s stock valued at $22,490,000 after buying an additional 527,859 shares during the last quarter. Finally, Ping Capital Management Inc. raised its stake in Bioceres Crop Solutions by 7.3% during the fourth quarter. Ping Capital Management Inc. now owns 44,000 shares of the company’s stock worth $268,000 after acquiring an additional 3,000 shares during the period. 17.68% of the stock is currently owned by institutional investors.

Bioceres Crop Solutions Price Performance

NASDAQ BIOX opened at $4.57 on Tuesday. The company has a 50-day moving average price of $5.23 and a two-hundred day moving average price of $6.36. The stock has a market cap of $286.59 million, a price-to-earnings ratio of 228.61 and a beta of 0.73. The company has a current ratio of 1.33, a quick ratio of 0.96 and a debt-to-equity ratio of 0.43. Bioceres Crop Solutions Corp. has a 52 week low of $3.69 and a 52 week high of $13.18.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on BIOX. Oppenheimer decreased their target price on Bioceres Crop Solutions from $13.00 to $12.00 and set an “outperform” rating for the company in a research note on Tuesday, January 28th. Lake Street Capital reduced their price objective on Bioceres Crop Solutions from $13.00 to $8.00 and set a “buy” rating for the company in a research report on Friday, February 7th. Finally, Canaccord Genuity Group lowered their price objective on Bioceres Crop Solutions from $7.00 to $6.50 and set a “buy” rating for the company in a research note on Thursday, February 13th. Four research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and an average target price of $9.88.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.